Início › Insuficiência Cardíaca › Wisconsin › Milwaukee
Ensaios clínicos de Insuficiência Cardíaca em Milwaukee, WI
16 estudos para Insuficiência Cardíaca estão buscando participantes em locais em Milwaukee e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
ELEVATE-HFpEF Clinical Study
Recrutando
- Froedtert Hospital, Milwaukee
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
RecrutandoFase 3
- ProHealth Care Research Institute and Cardiology Associates, Waukesha · a 17 mi de distância
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
RecrutandoFase 3
- Medical College of Wisconsin / Froedtert Hospital, Milwaukee
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RecrutandoFase 3
- Advocate Aurora Saint Lukes Medical Center, Milwaukee
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RecrutandoFase 3
- Milwaukee, WI Investigative Site 10061, Milwaukee
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Recrutando
- Aurora St. Luke's Medical Center, Milwaukee
Peripheral Venous Pressure (PVP) Trial
Recrutando
- Aurora St. Luke's Medical Center, Milwaukee
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
RecrutandoFase 2
- Froedtert Hospital - Center for Advanced Care, Milwaukee
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RecrutandoEstudo observacional
- Milwaukee, Milwaukee
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
RecrutandoEstudo observacional
- Medical College of Wisconsin, Inc (PI Address), Milwaukee
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecrutandoFase 3
- Aurora St. Luke's Medi Ctr, Milwaukee
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
RecrutandoFase 3
- Milwaukee, WI Investigative Site FIN-10428, Milwaukee
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Recrutando
- Advocate Aurora St. Luke's, Milwaukee
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recrutando
- Aurora Medical Group, Milwaukee
CCM OPEN HF Registry
RecrutandoEstudo observacional
- Advocate Aurora Health-St. Lukes, Milwaukee
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recrutando
- Advocate Aurora Research Institute, Milwaukee
Ensaios de Insuficiência Cardíaca em outras cidades
- New York City, NY51 estudos
- Boston, MA44 estudos
- Dallas, TX42 estudos
- Houston, TX36 estudos
- Cleveland, OH33 estudos
- Chicago, IL31 estudos
- Philadelphia, PA31 estudos
- San Francisco, CA29 estudos
- St. Louis, MO26 estudos
- Durham, NC26 estudos
- Kansas City, MO25 estudos
- Atlanta, GA25 estudos
Outros estudos em Milwaukee
- Câncer de Mama23 estudos
- Câncer de Pulmão de Não Pequenas Células22 estudos
- Câncer (todos os tipos)22 estudos
- Câncer de Pulmão21 estudos
- Mieloma Múltiplo21 estudos
- Câncer de Próstata20 estudos
- Linfoma folicular19 estudos
- Câncer de Pâncreas18 estudos
- Linfoma Não Hodgkin18 estudos
- Câncer de Ovário17 estudos
- Leucemia Mieloide Aguda17 estudos
- Linfoma de Burkitt16 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.